Howard C. Birndorf - 14 Nov 2022 Form 4 Insider Report for Adamis Pharmaceuticals Corp

Role
Director
Signature
/s/ David J. Marguglio, as attorney-in-fact for Howard C. Birndorf
Issuer symbol
N/A
Transactions as of
14 Nov 2022
Net transactions value
$0
Form type
4
Filing time
16 Nov 2022, 15:41:21 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMP Warrant to Purchase Common Stock Disposed to Issuer -58,824 -100% 0 14 Nov 2022 Common Stock 58,824 $8.50 Direct F1
transaction ADMP Warrant to Purchase Common Stock Award +58,824 58,824 14 Nov 2022 Common Stock 58,824 $8.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment to extend the term of an outstanding investor warrant originally issued on November 15, 2007.